NDC Product
Human Prescription DrugTecentriq Hybreza NDC 50242-933
- Generic Name
- Atezolizumab And Hyaluronidase-tqjs
- Dosage Form
- Injection
- Route
- Subcutaneous
- Marketing
- BLA
Active Listing
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Tecentriq Hybreza 1875 mg / 30,000 UNT in 15 mL Injection (RxCUI 2693899). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.